Judge Trims FTC's Pay-For-Delay Suit Against AbbVie
Teva Pharmaceuticals USA Inc. didn't violate federal antitrust law when it struck a deal with AbbVie Inc. and others to end patent infringement litigation, a Pennsylvania federal judge ruled Wednesday, dismissing...To view the full article, register now.
Already a subscriber? Click here to view full article